These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32482246)

  • 1. Methodologic considerations in randomized clinical trials in reproductive medicine.
    Venetis C; d'Hooghe T; Barnhart KT; Bossuyt PMM; Mol BWJ
    Fertil Steril; 2020 Jun; 113(6):1107-1112. PubMed ID: 32482246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction: How evident is the evidence?
    Simon C
    Fertil Steril; 2020 Jun; 113(6):1091-1092. PubMed ID: 32482243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large randomized controlled trials in infertility.
    Wang R; Chen ZJ; Vuong LN; Legro RS; Mol BW; Wilkinson J
    Fertil Steril; 2020 Jun; 113(6):1093-1099. PubMed ID: 32482244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrity of randomized controlled trials: challenges and solutions.
    Li W; van Wely M; Gurrin L; Mol BW
    Fertil Steril; 2020 Jun; 113(6):1113-1119. PubMed ID: 32387277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Prospectively Randomized Clinical Trials Have Been Rare in Reproductive Medicine and Will Remain So?
    Gleicher N; Kushnir VA; Barad DH
    Reprod Sci; 2016 Jan; 23(1):6-10. PubMed ID: 26282699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordination and planning of clinical research on a national and global level.
    Devall AJ; Out HJ; Mol BWJ; Duffy JMN; Collura B; Dyer S
    Fertil Steril; 2020 Jun; 113(6):1100-1106. PubMed ID: 32482245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology.
    Bian ZX; Li YP; Moher D; Dagenais S; Liu L; Wu TX; Miao JX; Kwan AK; Song L
    Zhong Xi Yi Jie He Xue Bao; 2006 Mar; 4(2):120-9. PubMed ID: 16529686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How are neonatal and maternal outcomes reported in randomised controlled trials (RCTs) in reproductive medicine?
    Braakhekke M; Kamphuis EI; van Rumste MM; Mol F; van der Veen F; Mol BW
    Hum Reprod; 2014 Jun; 29(6):1211-7. PubMed ID: 24713124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Big Trials or Big Data.
    King SB
    JACC Cardiovasc Interv; 2016 Apr; 9(8):869-870. PubMed ID: 27101918
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of research quality in major infertility journals.
    Glujovsky D; Riestra B; Coscia A; Boggino C; Comandé D; Ciapponi A
    Fertil Steril; 2012 Dec; 98(6):1539-43. PubMed ID: 22981173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.
    Hammad TA; Pinheiro SP; Neyarapally GA
    Clin Trials; 2011 Oct; 8(5):559-70. PubMed ID: 21878445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale, pragmatic randomized trials in the era of big data, precision medicine and machine learning. Valid and necessary, or outdated and a waste of resources?
    Stengel D; Augat P; Giannoudis PV
    Injury; 2023 May; 54 Suppl 3():S2-S9. PubMed ID: 36549979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: How evident is the evidence?
    Simon C
    Fertil Steril; 2020 Jul; ():. PubMed ID: 32624212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic randomized controlled trials reports: the statement of the hypothesis.
    Lee CF; Cheng AC; Fong DY
    Am J Ophthalmol; 2014 Jan; 157(1):254-259.e1. PubMed ID: 24210767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent controversies on comparative effectiveness research investigations: Challenges, opportunities, and pitfalls.
    Kirpalani H; Truog WE; D'Angio CT; Cotten M
    Semin Perinatol; 2016 Oct; 40(6):341-347. PubMed ID: 27423511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating equivalence and noninferiority trials.
    Dasgupta A; Lawson KA; Wilson JP
    Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the equivalence approach in reproductive health clinical trials.
    Piaggio G; Pinol AP
    Stat Med; 2001 Dec; 20(23):3571-7. PubMed ID: 11746338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE].
    Ernest P; Jandrain B; Scheen AJ
    Rev Med Liege; 2015; 70(5-6):232-6. PubMed ID: 26285444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An investigation of the statistical power of the effect size in randomized controlled trials for the treatment of patients with type 2 diabetes mellitus using Chinese medicine].
    Ma LX; Liu JP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):119-23. PubMed ID: 22500409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.